BIOMAT Database Logo BIOMAT Database Logo

Reduction of learned helplessness by central administration of quaternary naltrexone. 1992

J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Department of Psychology, Beaver College, Glenside, PA 19038.

Prior research has established that escape impairment resulting from prior inescapable shock (IS) could be reversed by the peripheral administration of the opiate antagonist naltrexone (NTX), but not the quaternary form of naltrexone (QNTX), which when systemically administered, does not readily pass the blood-brain barrier. As it was unclear whether the failure of systemically administered QNTX to reduce shuttle escape deficits following exposure to IS could be attributed to reasons other than the restricted access of QNTX to receptor sites in the brain, rats were affixed with chronic indwelling ventricular cannulae to allow direct brain administration of QNTX. The present experiment found a significant attenuation of the escape deficit produced by prior inescapable shock following the intracerebroventricular (ICV) administration of QNTX (10 micrograms/rat). These data provide further evidence of a mediational role for central opiate receptors in the expression of escape interference following inescapable shock.

UI MeSH Term Description Entries
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D011930 Reaction Time The time from the onset of a stimulus until a response is observed. Response Latency,Response Speed,Response Time,Latency, Response,Reaction Times,Response Latencies,Response Times,Speed, Response,Speeds, Response
D011957 Receptors, Opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behavior of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known. Endorphin Receptors,Enkephalin Receptors,Narcotic Receptors,Opioid Receptors,Receptors, Endorphin,Receptors, Enkephalin,Receptors, Narcotic,Receptors, Opiate,Endorphin Receptor,Enkephalin Receptor,Normorphine Receptors,Opiate Receptor,Opiate Receptors,Opioid Receptor,Receptors, Normorphine,Receptors, beta-Endorphin,beta-Endorphin Receptor,Receptor, Endorphin,Receptor, Enkephalin,Receptor, Opiate,Receptor, Opioid,Receptor, beta-Endorphin,Receptors, beta Endorphin,beta Endorphin Receptor,beta-Endorphin Receptors
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D004924 Escape Reaction Innate response elicited by sensory stimuli associated with a threatening situation, or actual confrontation with an enemy. Flight Reaction,Escape Reactions,Flight Reactions,Reaction, Escape,Reaction, Flight,Reactions, Escape,Reactions, Flight
D005260 Female Females
D006380 Helplessness, Learned Learned expectation that one's responses are independent of reward and, hence, do not predict or control the occurrence of rewards. Learned helplessness derives from a history, experimentally induced or naturally occurring, of having received punishment/aversive stimulation regardless of responses made. Such circumstances result in an impaired ability to learn. Used for human or animal populations. (APA, Thesaurus of Psychological Index Terms, 1994) Learned Helplessness
D000644 Quaternary Ammonium Compounds Derivatives of ammonium compounds, NH4+ Y-, in which all four of the hydrogens bonded to nitrogen have been replaced with hydrocarbyl groups. These are distinguished from IMINES which are RN Quaternary Ammonium Compound,Ammonium Compound, Quaternary,Ammonium Compounds, Quaternary,Compound, Quaternary Ammonium

Related Publications

J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Effects of naltrexone and cross-tolerance to morphine in a learned helplessness paradigm.
June 1997, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
A matter of timing: harm reduction in learned helplessness.
November 2014, Behavioral and brain functions : BBF,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Learned helplessness.
May 1989, Journal of gerontological nursing,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Learned helplessness.
January 1972, Annual review of medicine,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Learned helplessness.
January 2016, Contemporary clinical dentistry,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Learned helplessness.
February 2014, JEMS : a journal of emergency medical services,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Learned helplessness.
January 1986, Nursing times,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Learned helplessness.
December 2024, Lancet (London, England),
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Comparison of naltrexone and quaternary naltrexone after systemic and intracerebroventricular administration in pigeons.
June 1987, Neuropharmacology,
J E Blustein, and W G Whitehouse, and D J Calcagnetti, and J R Troisi, and D L Margules, and P J Bersh
Reversal of learned helplessness by nortriptyline.
January 1981, Progress in neuro-psychopharmacology,
Copied contents to your clipboard!